Abstract：
UNASSIGNED: To develop and evaluate Cochlear™ Remote Assist (RA), a smartphone-based cochlear implant (CI) teleaudiology solution. The development phase aimed to identify the minimum features needed to remotely address most issues typically experienced by CI recipients. The clinical evaluation phase assessed ease of use, call clarity, system latency, and CI recipient feedback.
UNASSIGNED: The development phase involved mixed methods research with experienced CI clinicians. The clinical evaluation phase involved a prospective single-site clinical study and real-world use across 16 clinics.
UNASSIGNED: CI clinicians (N = 23), CI recipients in a clinical study (N = 15 adults) and real-world data (N = 57 CI recipients).
UNASSIGNED: The minimum feature set required for remote programming in RA, combined with sending replacements by post, should enable the clinician to address 80% of the issues typically seen in CI follow-up sessions. Most recipients completed the RA primary tasks without prior training and gave positive ratings for usefulness, ease of use, effectiveness, reliability, and satisfaction on the Telehealth Usability Questionnaire. System latency was reported to be acceptable.
UNASSIGNED: RA is designed to help clinicians address a significant proportion of issues typically encountered by CI recipients. Clinical study and real-world evaluation confirm RA\'s ease of use, call quality, and responsiveness.
UNASSIGNED: The development phase involved mixed methods research with experienced CI clinicians. The clinical evaluation phase involved a prospective single-site clinical study and real-world use across 16 clinics.
UNASSIGNED: CI clinicians (N = 23), CI recipients in a clinical study (N = 15 adults) and real-world data (N = 57 CI recipients).
UNASSIGNED: The minimum feature set required for remote programming in RA, combined with sending replacements by post, should enable the clinician to address 80% of the issues typically seen in CI follow-up sessions. Most recipients completed the RA primary tasks without prior training and gave positive ratings for usefulness, ease of use, effectiveness, reliability, and satisfaction on the Telehealth Usability Questionnaire. System latency was reported to be acceptable.
UNASSIGNED: RA is designed to help clinicians address a significant proportion of issues typically encountered by CI recipients. Clinical study and real-world evaluation confirm RA\'s ease of use, call quality, and responsiveness.
摘要：
■要开发和评估Cochlear™RemoteAssist（RA），基于智能手机的人工耳蜗(CI)听力学解决方案。开发阶段旨在确定远程解决CI接收者通常遇到的大多数问题所需的最小功能。临床评估阶段评估易用性，调用清晰度，系统延迟，和CI收件人反馈。
■发展阶段涉及有经验的CI临床医生的混合方法研究。临床评估阶段涉及前瞻性单站点临床研究和16个诊所的实际使用。
■CI临床医生（N=23），临床研究中的CI接受者(N=15名成年人)和真实世界数据(N=57名CI接受者)。
■RA中远程编程所需的最小功能集，结合邮寄替换件，应使临床医生能够解决CI随访中常见的80%的问题。大多数接受者在没有事先培训的情况下完成了RA的主要任务，并对有用性给予了积极评价，易用性,有效性,可靠性,和对远程医疗可用性问卷的满意度。据报告，系统延迟是可以接受的。
RA旨在帮助临床医生解决CI接受者通常遇到的大部分问题。临床研究和真实世界评估证实了RA的易用性，通话质量,和响应性。
■发展阶段涉及有经验的CI临床医生的混合方法研究。临床评估阶段涉及前瞻性单站点临床研究和16个诊所的实际使用。
■CI临床医生（N=23），临床研究中的CI接受者(N=15名成年人)和真实世界数据(N=57名CI接受者)。
■RA中远程编程所需的最小功能集，结合邮寄替换件，应使临床医生能够解决CI随访中常见的80%的问题。大多数接受者在没有事先培训的情况下完成了RA的主要任务，并对有用性给予了积极评价，易用性,有效性,可靠性,和对远程医疗可用性问卷的满意度。据报告，系统延迟是可以接受的。
RA旨在帮助临床医生解决CI接受者通常遇到的大部分问题。临床研究和真实世界评估证实了RA的易用性，通话质量,和响应性。
